JB Capital’s Tandem Diabetes Care TNDM Stock Holding History

JB Capital’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-51,778	Closed	-$992K	–	248
2025 Q1	$992K	Buy	51,778 +12,565	+32%	+$368K	0.05%	117
2024 Q4	$1.41M	Buy	39,213 +5,484	+16%	+$185K	0.08%	100
2024 Q3	$1.43M	Buy	33,729 +2,259	+7%	+$95.8K	0.08%	104
2024 Q2	$1.27M	Buy	31,470 +2,499	+9%	+$104K	0.08%	106
2024 Q1	$1.03M	Buy	28,971 +4,908	+20%	+$131K	0.07%	105
2023 Q4	$712K	Buy	24,063 +7,811	+48%	+$162K	0.05%	118
2023 Q3	$338K	Buy	16,252 +6,288	+63%	+$173K	0.03%	140
2023 Q2	$245K	Buy	9,964 +2,998	+43%	+$96.5K	0.02%	154
2023 Q1	$283K	Buy	6,966 +793	+13%	+$32.8K	0.03%	137
2022 Q4	$277K	Buy	6,173 +419	+7%	+$19K	0.03%	142
2022 Q3	$275K	Buy	5,754 +129	+2%	+$7.07K	0.03%	136
2022 Q2	$333K	Buy	5,625 +467	+9%	+$38.3K	0.04%	182
2022 Q1	$600K	Buy	5,158 +477	+10%	+$55.7K	0.06%	150
2021 Q4	$705K	Buy	4,681 +919	+24%	+$124K	0.07%	140
2021 Q3	$449K	Buy	+3,762	New	+$414K	0.06%	180

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

JB Capital's TNDM Position: Q2 2025 in Review

JB Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 51,778 shares — an estimated $992K sold.

JB Capital first reported a position in TNDM in Q3 2021 and held it in 15 quarters. The position peaked at $1.43M in Q3 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

JB Capital reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
JB Capital sold 51,778 Tandem Diabetes Care shares in Q2 2025, an estimated $992K.
JB Capital first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 15 quarters.
JB Capital's Tandem Diabetes Care position peaked at $1.43M in Q3 2024.
270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on JB Capital's 13F filing for Q2 2025, filed 24 Jul 2025.